- 全部删除
您的购物车当前为空
GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) 是一种具有口服活性和高效性的 I 型蛋白精氨酸甲基转移酶 (PRMTs) 抑制剂 ,具有抗癌和抗肿瘤活性,抑制PRMT1,PRMT3,PRMT4,PRMT6,PRMT8的活性,可用于研究晚期实体肿瘤。

GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) 是一种具有口服活性和高效性的 I 型蛋白精氨酸甲基转移酶 (PRMTs) 抑制剂 ,具有抗癌和抗肿瘤活性,抑制PRMT1,PRMT3,PRMT4,PRMT6,PRMT8的活性,可用于研究晚期实体肿瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 497 | In stock | |
| 5 mg | ¥ 1,230 | In stock | |
| 10 mg | 待询 | In stock | |
| 25 mg | 待询 | 5日内发货 |
GSK3368715 dihydrochloride 相关产品
| 产品描述 | GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active and potent inhibitor of type I protein arginine methyltransferases (PRMTs) with anticancer and antitumor activity, inhibiting PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, and can be used to study advanced solid tumors. |
| 靶点活性 | PRMT4:1148 nM, PRMT6:5.7 nM, PRMT8:1.7 nM, PRMT3:48 nM, PRMT1:3.1 nM |
| 体外活性 | 在代表12种肿瘤类型的249个癌细胞系中,GSK3368715 dihydrochloride(EPZ019997 dihydrochloride)相对于DMSO处理细胞显示出50%或更高的生长抑制作用[1]。 |
| 体内活性 | GSK3368715 dihydrochloride (EPZ019997 dihydrochloride )在所有测试剂量下显著影响BxPC3异种移植瘤的生长。在150 mg/kg和300 mg/kg剂量组中,其分别使肿瘤生长减少了78%和97%[1]。 |
| 别名 | GSK3368715 2HCl, EPZ019997 dihydrochloride, EPZ019997 2HCl |
| 分子量 | 439.46 |
| 分子式 | C20H40Cl2N4O2 |
| CAS No. | 1628925-77-8 |
| Smiles | Cl.Cl.CCOCC1(COCC)CCC(CC1)c1n[nH]cc1CN(C)CCNC |
| 密度 | no data available |
| 存储 | store at low temperature,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 100 mg/mL (227.55 mM), Sonication is recommended. DMSO: 100 mg/mL (227.55 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容